Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Stem Cell Investigation|January 10, 2017
Hypomethylating agents after allogeneic blood stem cell transplantationThomas Schroeder, Christina Rautenberg, Rainer Haas, et al.
International Journal of Hematology|November 17, 2017
Hypomethylating agents for treatment and prevention of relapse after allogeneic blood stem cell transplantationThomas Schroeder, Christina Rautenberg, Rainer Haas, et al.
International Journal of Molecular Sciences|January 11, 2019
Relapse of Acute Myeloid Leukemia after Allogeneic Stem Cell Transplantation: Prevention, Detection, and TreatmentChristina Rautenberg, Ulrich Germing, Rainer Haas, et al.
European Journal of Haematology|May 9, 2019
Spontaneous remission in a patient with very late relapse of acute myeloid leukemia 17 years after allogeneic blood stem cell transplantationChristina Rautenberg, Jennifer Kaivers, Ulrich Germing, et al.
Expert Review of Hematology|July 20, 2019
Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromesGuido Kobbe, Thomas Schroeder, Christina Rautenberg, et al.
Bone Marrow Transplantation|September 3, 2020
Wilm's Tumor 1-guided preemptive treatment with hypomethylating agents for molecular relapse of AML and MDS after allogeneic transplantationChristina Rautenberg, Anika Bergmann, Sabrina Pechtel, et al.
Expert Review of Anticancer Therapy|July 24, 2020
Improving the accuracy of prognostication in chronic myelomonocytic leukemiaJennifer Kaivers, Esther Schuler, Barbara Hildebrandt, et al.
Blood Cancer Journal|November 14, 2019
Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDSChristina Rautenberg, Ulrich Germing, Sabrina Pechtel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|March 19, 2019
Comparison between Upfront Transplantation and different Pretransplant Cytoreductive Treatment Approaches in Patients with High-Risk Myelodysplastic Syndrome and Secondary Acute Myelogenous LeukemiaThomas Schroeder, Nadija Wegener, Michael Lauseker, et al.
European Journal of Haematology|May 14, 2021
Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1-mRNA expression in patients with AML and MDSChristina Rautenberg, Michael Lauseker, Jennifer Kaivers, et al.
Pageof 4